InvestorsHub Logo
icon url

doogdilinger

11/12/17 3:06 PM

#31234 RE: bluelucky #31231

I think Dr. Odidi could've easily secured partners on Rexista or Regabatin...but somewhere along the line he foolishly decided to go the plug and play route on rexista after misleading the market and his core shareholder base about the original rexista partnership plan.

Somewhere along the line Odidi either decided the partnership negotiation offers were too low...or he foolishly decided that someone would steal his technology.

But to this day he's never once tried to even bother trying to explain why he pulled the fast one on us and decided to try to get rexista FDA approved b4 securing a partner...and it's beyond infuriating knowing how much potential this stock had 4 years ago and what a disaster it's unfortunately become.

Next year is make or break time across the board for IPCI on all their relevant fronts...and I personally no longer have any faith in Dr. Odidi the scientist to suddenly start making smart CEO decisions. Sadly I think we're only going to be seeing more of the same things unfold here over the course of the next 12 months that we've already seen unfold over the past 4 years.

I sincerely hope my negative sentiment and pessimism is proven to be misplaced.

I still believe in the inherent potential value of Dr. Odidi's science...but time has proven that he has no clue how to execute and/or create any intrinsic value from that science.
icon url

tilator

11/12/17 3:53 PM

#31235 RE: bluelucky #31231

There is one major problem here. No one wants to partner with them. So Money is wasted developing worthless products.



I agree. They have to start making Glocophage and make a deal of it with this company:

https://www.express-scripts.com/